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High-valent Copper in Biomimetic and Biological Oxidations
William Keown1, J. Brannon Gary1, and T. Daniel P. Stack1
1Stanford University, Stanford, CA, USA
Abstract
A long-standing debate in the Cu-O2 field has revolved around the relevance of the Cu(III) 
oxidation state in biological redox processes. The proposal of Cu(III) in biology is generally 
challenged as no spectroscopic or structural evidence exists currently for its presence. The reaction 
of synthetic Cu(I) complexes with O2 at low temperature in aprotic solvents provides the 
opportunity to investigate and define the chemical landscape of Cu-O2 species at a small molecule 
level of detail; eight different types are characterized structurally, three of which contain at least 
one Cu(III) center. Simple imidazole or histamine ligands are competent in these oxygenation 
reactions to form Cu(III) complexes. The combination of synthetic structural and reactivity data 
suggests (i) that Cu(I) should be considered as either a one or two electron reductant reacting with 
O2, (ii) that Cu(III) reduction potentials of these formed complexes are modest and well within the 
limits of a protein matrix and (iii) that primary amine and imidazole ligands are surprisingly good 
at stabilizing Cu(III) centers. These Cu(III) complexes are efficient oxidants for hydroxylating 
phenolate substrates with reaction hallmarks similar to that performed in biological systems. The 
remarkable ligation similarity of the synthetic and biological systems makes it difficult to continue 
to exclude Cu(III) from biological discussions.
Biology & Cu-O2
Copper (Cu) is one the most frequently used metals in enzymes to activate dioxygen (O2) 
and the mushroom Cu enzyme Tyrosinase (Ty) provided the first example in 1955 of direct 
integration of an oxygen-atom from O2 into an organic product by an enzyme [1]. Given the 
diverse oxidative function of these enzymes, many different assemblies have evolved. 
Mononuclear to trinuclear copper active sites that activate O2 are now known, which are 
capable of oxidase transformations (e.g. alcohols to aldehydes), monooxygenase 
transformations (e.g. alkanes to alcohols), and full reduction of O2 to water [2–4]. Each 
enzyme is tuned remarkably to perform its specific reaction by exploiting the oxidizing 
power of O2 [4]. It is the controlled and efficient nature of these oxidative processes with O2 
that has captured the attention of the synthetic community with a vision of selective Cu-O2 
catalysts, using an earth-abundant metal and the most prevalent oxidant on the planet.
Copper in biology is considered currently to be a one electron reservoir shuttling between 
the Cu(I) and Cu(II) oxidation states, whether mediating an electron transfer (ET) process or 
activating O2 in an enzyme to oxidize a substrate. In the past two decades, it has become 
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clear from synthetic systems with ligation similar, if not identical, to the biological sites that 
Cu(I) complexes react with O2 to yield not only Cu(II) but also Cu(III) species – Cu(III)-O2 
species are thermodynamically stable relative to their Cu(I) and O2 starting materials. Yet, 
even with their characteristic Cu(III) spectroscopic signatures, no experimental evidence 
exists currently for its role in biology.
The scope of this review focuses on spectroscopically or structurally characterized high-
valent Cu-O2 complexes (i.e., Cu(III)) formed in the homogeneous reaction of Cu(I) with O2 
with nitrogen and oxygen ligation, and their subsequent reactivity with exogenous 
substrates. This review will concentrate primarily on cases where definitive spectroscopic 
and structural characterization of Cu(III) exist, though systems exhibiting reactivity 
hallmarks of Cu(III) species and lacking spectroscopic detection will be introduced, as 
interconverting valence isomers may be operative. While intramolecular ligand oxidation by 
these species defines reactivity possibilities, this review concentrates on intermolecular 
substrate reactivities, which, in the opinion of the reviewers, provide greater insights into 
development of useful stoichiometric or catalytic oxidants derived from O2. Furthermore, 
catalytic Cu-O2 systems for organic oxidations have been reported [5–8], but the 
involvement of Cu(III)-O2 intermediates is unknown.
Structural Types of Cu-O2 Species
The pursuit of the types of Cu-O2 species that can be formed in the reaction of simple Cu(I) 
complexes and O2 has fascinated synthetic and mechanistic chemists for more than seventy 
years. Their ligation lability and oxidative power confound this research, which has trended 
to low temperatures (−80 °C to −145 °C) to stabilize the complexes. The resulting structural 
diversity is remarkable, with 1:1 to 3:1 Cu:O2 stoichiometries, including several isomers 
within a given stoichiometry. Currently, eight different Cu-O2 types have been characterized 
structurally from the reaction of Cu(I) and O2: η1-end-on Cu(II) superoxide ES (2006) [9], 
η2-side-on Cu(II) superoxide SS (1994) [10], η2-side-on Cu(III) peroxide MP (2002) 
[11,12], dimeric cis-μ-η1:η1 Cu(II) peroxide CP (2014) [13], dimeric trans-η-1,2 Cu(II) 
peroxide TP (1988) [14], dimeric μ-η2:η2-side-on Cu(II) peroxide SP (1989) [15], dimeric 
Cu(III) bis-μ2-oxide O (1996) [16], and trinuclear Cu(III)Cu(II)Cu(II) bis-μ3-oxide T (1996) 
[17] (Fig. 1). Three of the eight types contain a Cu(III) center derived from the reaction of 
Cu(I) and O2.
This structural diversity is associated with copper nuclearity and the reduced O2 binding 
mode. The stoichiometries of these complexes are determined primarily by ligand steric 
demands and ligand denticity, which is succinctly summarized through a ligand steric 
continuum [19] (Fig. 1). The most sterically demanding ligands, which effectively preclude 
copper dimerization, yield mononuclear superoxide or peroxide species, with the superoxide 
ligated either in a side-on (ES) or end-on fashion (SS) [20]. Less demanding ligands, if 
tetradentate, preferentially stabilize a TP species (Cu-Cu, ca. 4.4 Å) or a CP species (Cu-Cu, 
ca. 3.8 Å), if the ligand enforces a cis geometry. Tri- or bi-dentate ligands collapse to SP 
species (Cu-Cu, ca. 3.5 Å) or a Cu(III)-containing O species (Cu-Cu, ca. 2.8 Å). Bidentate 
amine ligands (e.g., diamines, histamines, pyridylamines) almost exclusively form O 
species, which constitute the largest family of synthetic Cu-O2 species to date [19,21,22]. 
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Finally, the least sterically demanding bidentate ligands (e.g., primary amines, methylated 
amines, histamines) form the most compact Cu-O2 core, a trinuclear T cluster (Cu-Cu ca. 
2.7 Å) [2,23]. Ligands that support the Cu(III) species of interest for this review are shown 
in Fig. 2.
While ligand steric demands are a dominant force in determining the Cu-O2 binding mode, 
the nature of the ligating groups and the Cu(I) geometry are also important. Strongly 
donating, basic amines or anionic nitrogen donors not only stabilize the contracted Cu(III) 
center but also create more reducing Cu(I) precursor complexes, facilitating their reaction 
with O2 [2,24]. If a productive reaction is to occur, the Cu(I) precursor must provide inner-
sphere binding access for O2 to allow association and ET; Cu(I) complexes in a tetrahedral 
geometry are typically not reactive with O2. Three-coordinate trigonal or T-shape complexes 
or four-coordinate trigonal monopyramidal geometries are generally the most reactive Cu(I) 
precursor geometries, as O2, an impotent ligand, is not required to compete with a weakly 
associating solvent or counteranion.
Spectroscopic Characterization
The spectroscopic and metrical parameters for the eight structurally characterized Cu-O2 
species are surprisingly distinct, which allows for solution characterization by a combination 
of optical, vibrational, and x-ray absorption spectroscopies (XAS). The reaction of d10 Cu(I) 
complexes with O2 generally lead to significant changes in the optical spectra with the 
appearance of intense ligand to metal charge transfer (LMCT) bands, generally characterized 
as oxygen to copper charge transfers. The optical comparison in Fig 3. of the three most 
common 2:1 species (TP, SP, O) effectively allows for their unambiguous characterization, 
assuming full formation of a single Cu-O2 species. Redox titrations with weak H-atom 
donors such as ascorbic acid or carboxyferrocene provide critical insights into formation 
yields [21,23,25]. Of course, the energies of the LMCT bands are sensitive to the nature of 
the ligand, but the optical features are generally consistent. Recent studies on O and T 
species with varied amine and imidazole ligation correlate more donating ligation to a 
systematic blue-shifting of the LMCT optical bands for complexes of the same structural 
type [21,22]. As many of these complexes are thermally sensitive and can exist as an 
equilibrium of isomers in solution (vide infra), resonance Raman (rR) is generally preferred 
over infrared spectroscopic characterization, as the former enables optical and vibrational 
correlations [26–28]. A superoxide stretching frequency (960–1130 cm−1) [4] is 
distinguished readily from that of a peroxide (720–960 cm−1) [2,24,13] or that of the bis-
oxide core (590–620 cm−1) [29,30]. The combination of optical and rR spectroscopy is 
extremely powerful for distinguishing among these species. Solution Cu K-edge XAS is also 
a valuable tool to differentiate between the SP (Cu-Cu, ca. 3.6 Å), O (ca. 2.8 Å), and T (ca. 
2.7 Å) species through their Cu-Cu separations; acceptable fits to their Extended X-ray 
Absorption Fine Structure (EXAFS) require a Cu-Cu scattering distance that is effectively 
invariant among all model fits for a single complex. The copper pre-edge feature of these 
absorptions, albeit weak, also has characteristic oxidation information encoded in their 
energies, with Cu(I) absorbing at 8984 ± 1 eV, Cu(II) at 8979 ± 0.5 eV, and Cu(III) at 8981 
± 0.5 eV [31,32]. The intensity of Cu(II) and Cu(III) features generally increase with 
distortion from a planar coordination geometry [33]. However, the Cu(II) pre-edge intensity 
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is usually more intense than that of Cu(III) for a given ligation environment. Consequently, 
the pre-edge of a T complex, composed of two-thirds Cu(II) and one-third Cu(III), only 
reveals Cu(II) features; the higher energy feature associated with Cu(III) is obscured by the 
Cu(II) pre-edge absorption along with the rising edge [33].
General Reactivity
Beyond the wealth of spectroscopic and structural data provided by these synthetic 
complexes, detailed mechanistic studies provide insights into their reactivity tendencies with 
external substrates. The oxidative reactivity of these reagents can vary from electrophilic to 
nucleophilic. Generally, the superoxide species are limited in their oxidizing abilities; if 
reactivity is observed, it is usually only with weak O-H and C-H bonds [34]. Reactivity 
characterization of the CP species is incomplete currently as reactivity with weak C-H bonds 
is only observed upon warming, leaving the possibility of forming a different active species 
upon decomposition [13]. The end-on peroxide of TP has nucleophilic character, as it is 
protonated readily, does not oxidize PPh3, and oxidizes benzaldehyde to benzoic acid 
[35,36]. By contrast, the side-on peroxide of SP, while susceptible to protonation by acid 
[35,37,38], is capable of PPh3 oxidation and can oxidize phenolates to catechols and 
catechols to quinones through an electrophilic mechanism [34,37]. The O species are the 
most potent oxidants, capable of phenolate hydroxylation, C-F activation, and C-H 
activation [2,18,25,39–41]. The extremely compact nature of the T species precludes most 
reactivity, with the exceptions of proton-coupled electron transfer (PCET) from weak O-H 
substrates and oxidation of PPh3 [23,42–44].
Cu(III) Geometric Preferences and Redox Potentials
Cu(III) has been excluded generally from biological discussions, as the positive reduction 
potentials of most mononuclear Cu(III) complexes are significantly above 1 V vs NHE, 
which would lead to oxidation of proximal protein residues. The highest reported reversible 
copper potential is that of the blue copper site of fungal laccases, a Cu(II)/(I) process, at ca. 
0.8 V [45]. By comparison, the reduction of [Cu(III)(cyclam)]3+ occurs above 1.5 V, with a 
macrocyclic tetraamine ligand almost ideally suited to match the planar coordination 
preference of a d8 Cu(III) center [46]. However, the addition of anionic ligation significantly 
attenuates the positive reduction potentials. The Margerum group demonstrated clearly that 
monomeric Cu(III)/Cu(II) potentials can be moved within the biological range by including 
strong anionic ligation in a planar coordination geometry: a triply deprotonated glycine 
tripeptide Cu(III) complex with two amidate ligands has a potential in water near 0.9 V, and 
even more donating ligands lower the reduction potentials to near 0.4 V [47,48]. This 
principle is further demonstrated by a dianionic pyridinedicarboxamide ligand in 
conjunction with a ligated hydroxide that creates a neutrally charged Cu(III) species with a 
reduction potential of ca. 0.7 V [49,50], which is reactive with moderately strong C-H 
bonds. Though deprotonated amide ligands are now reported to ligate Fe, Co, and Ni centers 
in enzymes [51–54], no such ligation is known currently for any copper enzymes. The redox 
potentials of a variety of mononuclear Cu complexes with neutral to trianionic ligands, 
presented by the Krüger group [55], clearly show a correlation of anionic ligation to lower 
Cu(III) reduction potentials (Fig. 4). Copper centers that react with O2 have an advantage in 
Keown et al. Page 4
J Biol Inorg Chem. Author manuscript; available in PMC 2018 June 21.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
stabilizing Cu(III), as the reduced O2 species generate anionic ligation. In the extreme of 
four electron reduction of O2, two dianionic oxide ligands are formed possessing the ability 
to bind the copper centers in a planar geometry, thereby stabilizing the Cu(III) oxidation 
state. This analysis suggests that if Cu(III) plays a mechanistic role in a copper, O2-
activating enzyme, the bi- and trinuclear sites would be foremost candidates.
Mononuclear Cu(III) Examples
Examples of mononuclear Cu-O2 species are less common than their multinuclear 
counterparts presumably due to their tendency to dimerize rapidly in homogenous solutions. 
This transient existence often confounds their characterization. While several examples of 
mononuclear Cu(II)-superoxide complexes exist [9,56–58,20], only a single example of a 
mononuclear, Cu(III)-peroxide, MP, is known: the Cu(I) complex of a sterically demanding 
β-diketiminate (Dk) ligand directly oxygenates to a mononuclear Cu-O2 species [11]. X-ray 
crystallography reveals short Cu-O/N distances of ca. 1.8 Å with an O-O separation of ca. 
1.4 Å, consistent with a peroxide level O2 species [12]. Spectroscopic studies of three MP 
derivatives show rR O-O vibrations in the 750–930 cm−1 range and a pre-edge Cu K-edge 
XAS feature at 8981 eV, both of which support a Cu(III) peroxide description [24]. This 
contrasts with the reaction of O2 with sterically bulky tris-pyrazolylborate Cu(I) complexes, 
an overall neutral complex similar to Cu(I)-Dk, that yields a side-on Cu(II)-superoxide 
species, SS [10].
Despite the tendency of Cu(III) complexes to be avid oxidants, the MP complexes exhibit 
limited reactivity with exogenous substrates; no reaction is reported with weak O-H or C-H 
substrates, and PPh3 displaces the bonded O2 to yield a Cu(I)-PPh3 complex, suggesting 
weak nucleophilic activity. Density functional theory (DFT) calculations indicate that these 
Cu(III)-peroxides possess modest reduction potentials and are weakly basic upon reduction, 
supporting the limited PCET abilities. This stabilized Cu(III) center presumably results from 
the strong anionic donation from the Dk ligand. While this sterically demanding anionic 
ligation promotes the reactivity of the ligated Cu(I) with O2 and prevents dimerization, its 
stabilizing effect attenuates reactivity [24,59].
Binuclear Cu(III) Examples
The reduction of O2 to a peroxide or oxide level is more thermodynamically favorable than 
to a superoxide level, and four different 2:1 Cu:O2 isomers are known currently (i.e., TP, CP, 
SP, O) [2,60]. The distinct spectroscopy of each isomer is consistent with their strikingly 
different metrical parameters and substrate reactivity (Fig. 3). While the reactivity of the CP 
species has not been extensively explored [13], the end-on peroxide of the TP species 
primarily reacts as a nucleophilic oxidant [36], and the SP [61] and O [18,62] species react 
as electrophilic oxidants. The O species are of particular interest because of their varied 
substrate scope. While attributing a reactivity to a specific structural type is convenient, 
active oxidant identification can be complicated by the existence of facile equilibria among 
the 2:1 species (vide infra) [16,28,38,63,64].
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O Species Discovery
The O species, initially observed in 1993 [65], was characterized in 1995 by the Tolman 
group using a sterically demanding triazacyclononane ligand; oxygenation of 
[(Bn3TACN)Cu(I)(MeCN)]+ at −80 °C produced distinct optical features, rR vibrations, and 
Cu-Cu distance from Cu K-edge XAS [66]. The short Cu-Cu distance (ca. 2.8 Å) was 
consistent with high-valent copper centers, though initially assigned as a bis-Cu(II)-bis-oxyl 
formulation from calculations. Subsequent crystallographic characterization confirmed Cu-O 
distances (ca. 1.8 Å) much shorter than previously observed for Cu(II) complexes [16]. The 
facial-capping trinitrogen ligation of each TACN ligand flexes to allow two short Cu-N 
distances (ca. 2.0 Å) in the plane defined by the Cu2O2N4 atoms and one long axial Cu-N 
distance (ca. 2.3 Å) creating a coordination environment suitable for Cu(III). Each copper 
center provides two electrons to fully reduce O2, forming two anionic oxide ligands. 
Intermolecular reactivity of this complex and the related iPr3TACN complex is limited given 
the large steric demands of the ligands. However, intramolecular dealkylation of N-alkyl 
ligand substituents, a two electron, two proton process, is observed upon thermal decay 
[16,67].
Most O species are thermally sensitive, and most investigations have been performed at 
−80 °C to −145 °C. The thermal decay is usually associated with ligand oxidation; in the 
case of N-alkyl substituents, the weakest C-H(D) bond is removed in a unimolecular rate 
limiting step upon warming, as evidenced by a large primary kinetic isotope effect (KIE) 
with deuterium substitution [68–70]. Formation of a carbinolamine intermediate is proposed 
generally, which subsequently decomposes to an aldehyde or ketone product and dealkylated 
amine. A O species can also thermally decay through oxidation of ligand aryl substituent to 
yield a phenolate through a direct, electrophilic oxygen-atom transfer [71,72]. These 
intramolecular oxidations demonstrate that the Cu2O2 O core can be reactive to either alkyl 
or aryl C-H bonds. Numerous examples of O species are now characterized to be stabilized 
by peralkylated diamines [19,21], triamines [16,73], and hybrid ligands containing alkylated 
amines combined with aromatic nitrogen or guanidyl groups [22,72,74]. Bidentate ligation 
provides a coordination environment that best matches the planar preference of a Cu(III) 
center with the added benefit of providing axial access of substrates to the Cu2O2 core [75].
O and SP Equilibrium
Oxygenation of [(iPr3TACN)Cu(I)(MeCN)]+ at −80 °C under specific conditions yields a 
remarkable finding by the Tolman group of an equilibrium of two structural types, O and SP 
isomers, in optically-measurable amounts. This isomeric interconversion involves the 
forming and breaking of the O-O bond with concurrent reduction and oxidation of the 
Cu(III) and Cu(II) centers, respectively [16,76]. Oxygenation of the more sterically 
demanding [(tBu3TACN)Cu(I)(MeCN)]+ yields exclusively a SP species [73,77]. Thus, the 
variation of the alkyl substituents on the TACN ligand backbone from Me [78] to tBu [73] 
generates optically pure O to SP species, respectively, illustrating a ligand steric continuum 
resulting in a Cu-O2 speciation change. The variation of Cu-O2 structural type with variation 
of alkyl substituents is even more extreme with bidentate, nitrogenous ligands as SP, O, and 
T species can all be formed as clearly demonstrated by the Stack and Itoh groups [19].
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The potential energy surface (PES) of the O ↔ SP equilibrium can be relatively flat 
depending on the ligand choice, such that speciation is affected by many subtle variables 
including solvent, temperature, and counteranion. In the cases where measured, the O 
species is favored enthalpically (i.e., the equilibrium is biased to the O species at lower 
temperatures), while SP species are favored entropically [26,63,79]. More significant 
changes, such as axial coordination of a bridging ligand or addition of a more coordinating 
anion, can trigger isomerization of a O isomer to its corresponding SP species, as 
demonstrated with the bidentate ligand TEPD (N,N,N’,N’-tetraethylpropylenediamine) [79]. 
Such valence isomerization equilibria has now been extended by the Karlin group to include 
TP and O species, and calibrated DFT calculations support a relatively flat PES among three 
2:1 Cu:O2 isomers [28].
Optically characterized O species are known to react with an array of externally added 
substrates including weak O-H, S-H, and C-H bonds, such as ascorbic acid derivatives, 
phenols, catechols, thiols, alkylated amines, and hydroxylamines at low temperatures. In 
most cases, these reactions result in formation of Cu(II)-hydroxide products, which are the 
thermodynamic products of this chemistry. This suggests that the O species is ideally suited 
for two proton, two electron oxidations. The O complexes can also act as an oxygen-atom 
transfer reagent for reactive, exogenous substrates such as PPh3 [63]. Understanding the 
factors that control this diverse exogenous reactivity is important for dissecting reactivity in 
biological systems and development of selective chemical oxidants.
Oxidase Reactivity of O Species with External Substrates
Significant insights into the exogenous substrate reactivity of the O species initially came in 
1999 from the stoichiometric oxidation of alcohols to yield carbonyl products [70]. 
Screening greater than ten different O species ligated by alkylated diamines identified 
OTMPD (TMPD = N,N,N’,N’-tetramethylpropylenediamine) as the most reactive of the 
group [69]. The small methyl substituents of TMPD are beneficial, allowing for substrate 
access to the Cu2O2 core. Additionally, the relatively strong N-methyl C-H bonds generate a 
more stable O species, as the N-dealkylation pathway is attenuated significantly; more than 
90% of the intact ligand is recovered upon thermal decomposition [69]. OTMPD is 
indefinitely stable at −80 °C and sufficiently stable for reactivity studies at −40 °C. OTMPD 
reacts with alkyl and benzylic alcohols stoichiometrically to produce aldehyde or ketone 
products in yields of 60–90% based on oxidant using two equivalents of alcohol per OTMPD. 
The isolated yields can be improved with additional equivalents of OTMPD as subsequent 
oxidation of product is not observed. Stoichiometric addition of Et3N greatly enhances the 
rate of alcohol oxidation, allowing the reaction to be performed at −80 °C in less than three 
hours with a dramatic increase in selectivity for primary over secondary alcohols.
The rate limiting step does not involve the Cα-H bond cleavage, as the rates of PhCH2OH 
and PhCD2OH oxidation at −40 °C are effectively identical, but the product determining 
step (PDS) does involve Cα-H(D) bond cleavage as evidenced by an intramolecular KIE of 
5 for PhCHDOH [70,80]. The lithium salt of PhCHDOH reacts on mixing at −80 °C with a 
similar KIE of 5, suggesting that alcohol and alkoxide oxidation occurs through the same 
PDS. Combined, these data suggest a mechanism in which the alcohol binds to OTMPD and, 
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upon deprotonation, rearrangement positions the alkoxide within the equatorial plane of the 
Cu2O2 O core enabling C-H activation and substrate oxidation. The amine ligand must be 
sufficiently flexible to allow for this rearrangement, an attribute of the 6-membered TMPD 
chelate. The four electron oxidation of primary amines to nitriles also occurs using two 
equivalents of OTMPD at −80 °C through the intermediacy of an imine. As with alcohol 
substrates, a significant primary over secondary amine selectivity exists, supporting an initial 
binding to the Cu2O2 core. However, OTMPD does not react in any appreciable way with the 
weak C-H bonds of 1,4-cyclohexanediene (CHD) or dihydroanthracene (DHA) at −80 °C 
over a three-hour period. Beyond performing near-quantitative oxidation of weak O-H and 
S-H substrates (e.g., phenols to phenoxyl radicals or bis-phenols; catechols to quinones; 
thiols to disulfides) through either a sequential electron, proton transfer (ETPT) or concerted 
PCET mechanism, an oxygen atom of OTMPD can be transferred to an exogenous substrate, 
initially demonstrated with PPh3, under purged O2 conditions [63]. This detailed reactivity 
scope clearly demonstrates the oxidizing proclivity of the Cu2O2 O core and the importance 
of substrate access to the copper centers.
C-H Oxidase Reactivity of O Species with External Substrates
In 2001, the Fukuzumi and Itoh groups reported the first example of a O species that reacts 
with exogenous substrates containing weak C-H bonds, such as N-methyl-9,10-
dihydroacridine (AcrH2) and CHD to yield N-methylacridinium ion and benzene, 
respectively [81]. Curiously, this oxidase reactivity is second order with respect to the O 
species with C-H bond cleavage as rate limiting. Prior work from this group reported that a 
closely related bidentate ligand with appended benzylic C-H groups exhibited intramolecular 
monooxygenase reactivity [72,82]. Intermolecular monooxygenase activity on aliphatic C-H 
substrates is still not documented for an O species.
Despite the wealth of structural, spectroscopic, and reactivity data from O species, their 
biological significance is generally excluded given the absence of any known characteristic 
spectroscopic signature of Cu(III) from a biological system in conjunction with limited use 
of biologically relevant ligands in the synthetic investigations [4,83]. Oxygenation of Cu(I)-
histamine, Cu(I)-alkylhistamine or Cu(I)-imidazole complexes do not yield spectra 
consistent with a pure O species even at −145 °C [23,39]. A pure O species with imidazole 
ligation, only disclosed in 2014, requires an indirect, synthetic pathway through a ligand 
exchange reaction with a preformed O species at −125 °C [22,84]. Two equivalents of Nτ-
butylhistamine (Nτ ≡ Nε), Nτ,N,N-trimethylhistamine (HIS), or even propylenediamine 
(PD) displace the TMPD ligands from OTMPD at −125 °C to generate new O species that 
contain histamine ligation (OHIS) or exclusive primary amine ligation (OPD) in yields 
greater than 80% by redox titrations. The facile oxidation of primary amines by OTMPD is 
not competitive with the fast ligand exchange (ca. 10 min) at −125 °C, allowing respectable 
yields of OPD and OHIS.
The displacement of TMPD by these ligands clearly indicates a greater thermodynamic 
stability of a O species with primary rather than tertiary amines, a trend that correlates to 
DFT calculations [21]. These calculated structures clearly display shorter Cu(III)-N 
distances to primary amines than to tertiary amines by ca. 0.05 Å. The one primary amine 
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Cu(III)-N distance, crystallographically characterized at 1.9 Å, is even shorter than those 
predicted by DFT calculations [85]. The primary amines, though less basic than tertiary 
amines in the gas phase, are stronger donors to the compact Cu(III) centers, as their lesser 
steric demands allow closer proximity and greater orbital overlap. Indeed, the O species with 
primary amine ligation have LMCT bands that are blue-shifted relative to the tertiary 
amines. DFT calculations show the acceptor orbital is antibonding with respect to the Cu-N 
bonds; stronger Cu-N bonding should increase the optical transition energy, as observed 
experimentally [21]. More remarkable is that ligation from an imidazole is more 
thermodynamically stabilizing than from a primary amine for O species. From ligand 
exchange reactions, HIS is capable of ligand exchange with OPD to produce OHIS with a 
corresponding blue-shift of the LMCT band (378 to 363 nm) [22]. DFT calculations support 
an even shorter imidazole Cu(III)-N distance, and time-dependent DFT optical predictions 
correlate with the observed optical blue-shifting. These simple ligand exchange reactions 
provide the unanticipated result that imidazole ligation best stabilizes a O species of all 
neutral nitrogenous ligands examined to date.
Despite the greater thermodynamic stability of OPD compared to OTMPD, the former 
activates the weak C-H bond of AcrH2 and the latter does not. Isodesmic DFT reactions 
suggest that OPD is a stronger hydrogen-atom acceptor than OTMPD, assuming that the 
hydrogen-atom reduced product is a Cu(III)Cu(II)-oxide-hydroxide species. On a 
thermodynamic basis, OPD should be a faster hydrogen-atom abstracting agent compared to 
OTMPD for externally added substrates, which is observed experimentally. Additionally, this 
reactivity trend is consistent with greater substrate accessibility to the OPD Cu2O2 core. 
Using CHD as a weak C-H atom substrate, the lowest energy pathway calculated by DFT is 
along the O-O vector (Fig. 5). N-alkylation impedes this pathway, consistent with the 10-
fold slower reactivity observed from the O species generated with the more sterically 
demanding N,N’-dimethylpropylenediamine with AcrH2 [21].
Monooxygenase Reactivity of O Species
While exogenous oxidase reactivity involving either an ETPT or PCET pathway is amply 
demonstrated in the literature for O species, exogenous monooxygenase reactivity has been 
demonstrated only for phenolate hydroxylation in a limited number of cases in a 
homogeneous solution. By contrast, a heterogenized, discrete O species on nanoparticles are 
also known to catalytically oxidize toluene to benzyl alcohol and benzaldehyde at elevated 
temperatures using O2 as the oxidant [86]. In all cases, facile substrate accessibility to the 
Cu2O2 core is possible [25,28,40,87].
In the case of phenolate hydroxylation, initial axial approach of a phenolate to a copper 
center followed by rapid rearrangement into an equatorial position of the O core allows for 
an inner-sphere hydroxylation to occur [18]. This mechanistic postulate is different from that 
generally accepted for Tyrosinase enzymes (Ty), which are proposed to operate through a 
side-on Cu(II) peroxide active oxidant (vide infra) [88,89].
Active oxidant identification is a difficult task given the possibility of multiple Cu-O2 
structural types existing in facile equilibria. An informative example that showcases these 
Keown et al. Page 9
J Biol Inorg Chem. Author manuscript; available in PMC 2018 June 21.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
intricacies is found in the work of the Suzuki group that observes epoxidation of styrene and 
hydroxylation of tetrahydrofuran (THF) at −80 °C by a spectroscopically characterized SP 
species [64]. 18O2 experiments confirm the source of the oxygen-atom for the epoxidation, 
and the large H(D) KIE of 50 for THF hydroxylation support a rate limiting C-H activation. 
Subsequent reactivity studies report not only exogenous phenolate hydroxylation but also C-
H activation with a wide range of C-H substrates including CHD, fluorene, and toluene. As 
this latter reactivity is generally associated with a O rather than a SP species [90], the 
authors did not exclude the possible role of a O isomer in these oxidations.
A clearer example of step-by-step hydroxylation of an exogenous phenolate by a O species 
is the reactivity reported by the Costas group in 2008 [40]. Oxygenation of their 
binucleating, Cu(I) polydentate amine complex at −80 °C yields the characteristic optical 
and rR spectroscopic features of a O species. Addition of 1.5 equivalents of exogenous 
phenolate forms a new intermediate species, A (Fig. 6a), with spectroscopic features similar 
to the parent O species, yet with new visible absorption features suggestive of direct 
phenolate ligation. This complex thermally decays by a first order process to form catechol 
products through an electrophilic oxidation mechanism, evidenced by slower reactivity of 
electron deficient phenolates. The simplest interpretation of this data is that a Cu(III) O 
species is capable of stoichiometric electrophilic hydroxylation through an inner-sphere 
mechanism.
Support for a O species acting as the active oxidant for exogenous phenolate hydroxylation 
was proposed initially in 2005 starting from a side-on peroxide species, SPDBED, using the 
sterically demanding, bidentate N,N’-di-tert-butylethylenediamine (DBED) ligand [18]. 
While SPDBED hydroxylates added phenolates in high yields relative to oxidant at −80 °C, 
no oxidation intermediate is observed. Cooling the reacting mixture to −125 °C stabilizes a 
transient intermediate, ADBED, with a 18O2-sensitive stretch at 590 cm−1, a 2.8 Å Cu-Cu 
distance, and an intense LMCT band at 418 nm, all fully consistent with a Cu(III)2O2 bis-
oxide core (Fig. 6b). Additional visible absorptions are assigned as equatorially ligated 
phenolate to copper LMCTs through comparative rR studies with 16O and 18O substituted 
phenolates, features similar to those reported by Costas et al. (vide supra). ADBED undergoes 
first-order decay at −125 °C to produce hydroxylated products with the oxygen-atom derived 
from O2. A Hammett ρ-value of −2.2 and an inverse deuterium KIE for the oxidized ortho-
carbon support an electrophilic oxidation mechanism. The simplest interpretation of these 
results is that SPDBED oxidizes phenolates through the intermediacy of a O species that 
forms as a result of phenolate binding to the initial SP species.
More recent results have created SP species with exclusive imidazole ligation that exhibit a 
similar type of SP to O isomerization triggered by phenolate ligation, followed by a first-
order decay with associated phenolate hydroxylation. In 2012 the self-assembly of SP 
complexes from 6 monodentate imidazoles, Cu(I), and O2 in near quantitative yields was 
reported, albeit the imidazoles required a non-hydrogen substituent adjacent to the ligating 
imidazole nitrogen atom, Cu-Nπ ligation (Nπ ≡ Nδ), to be contrasted with the less 
sterically demanding Nτ ligation observed exclusively in oxygenated Ty (oxyTy) and oxyHc 
[37,88,92] (Fig. 7). These SP complexes hydroxylate electron deficient phenolates to 
catechol products without any intermediate detection at −125 °C, and cooling to −145 °C 
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only slows this hydroxylation reactivity. In 2016, the biologically-relevant Nτ ligation in 
synthetic SP complexes became possible by working at −145 °C; 1-methylimidazole 
(SP1MeImd), 4-methylimidazole (SP4MeImd), and imidazole (SPNHImd) complexes are now 
characterized [39]. The remote positioning of each imidazole substituent in SP4MeImd and 
SP1MeImd results in much more exposed Cu2O2 SP cores. Indeed, SP1MeImd reacts with 
exogenous, electron-deficient phenolates at −145 °C to generate an intermediate, A1MeImd, 
with a similar optical spectrum to ADBED, which thermally decomposes to form catechols 
(Fig. 6c). The Cu K-edge XAS of A1MeImd reveals a pre-edge feature and a short Cu-Cu 
distance (ca. 2.8 Å), both consistent with a O species. The chemical precedence of a Cu(III) 
species in a ligand environment remarkably similar to oxyTy suggests that there is no 
chemical reason, thermodynamic or kinetic, to exclude Cu(III) from discussions of 
biological redox processes.
Other characterized O species with amine, imine, and hybrid guanidine/amine ligands 
exhibit similar stoichiometric electrophilic hydroxylation reactivity with added phenolates, 
albeit without detection of an A-like intermediate species (Fig. 6d & 6e). Phenolate 
hydroxylation by a TP species has also been proposed using an asymmetric, hexadentate 
ligand (Fig. 6f), a reactivity behavior not consistent with its general oxidative tendencies 
[38]. Motivated by a measureable O ↔ TP equilibrium, the TP phenolate reactivity is 
suggested now to operate through a O species [28]. Chemical precedence that Cu(III) O 
species are good electrophilic hydroxylation reagents is now firmly established, yet with 
only a single example of biological nitrogenous ligation, the relationship to the active 
oxidant in Ty is still tenuous.
Trinuclear
The highest nuclearity synthetic cluster known to form directly from the reaction of Cu(I) 
and O2 is the trinuclear T cluster with a single Cu(III) center. These synthetic clusters are 
much less prevalent than O species. In part, this dearth is due to the more stringent 
constraints of formation of the extremely compact T clusters, coupled with greater detection 
difficulties of their higher energy and lower intensity optical features compared to other Cu-
O2 species.
The disclosure of a T cluster in 1996 by the Stack group resulted from the oxygenation of 
[(TMCD)Cu(MeCN)]+ (TMCD = (1R,2R)-tetramethylcyclohexanediamine) at −80 °C. The 
3:1 Cu:O2 stoichiometry by manometry and the unique optical spectrum defined a new 
structural type, which was confirmed by X-ray diffraction [17]. The metrical parameters of 
the two-fold symmetric, tricationic L3Cu3O2 cluster clearly support a valence-localized 
Cu(III)Cu(II)Cu(II) bis-μ3-oxide cluster. Each copper center maintains a planar geometry, 
with two ligands from the diamine and two from the oxide ligands. The unique Cu site has 
shorter Cu-O bonds (ca. 1.8 Å) than the symmetric Cu sites (ca. 2.0 Å), indicative of a 
higher oxidation state. Ferromagnetic coupling of two Cu(II) centers, dictated by the acute 
Cu(II)-O-Cu(II) angle, leads to a paramagnetic, triplet ground state. While EXAFS modeling 
corroborate the metrical parameters of the X-ray structure, the more intense Cu(II) pre-edge 
feature at 8979 eV masks any potential lower intensity Cu(III) feature at 8981 eV [31,32]. A 
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limited number of other T complexes formed with non-sterically demanding, bidentate 
ligation are known, primarily characterized through their optical spectra [42,43,93,94].
Reactivity from T clusters remains limited. Generally, T clusters react with weak hydrogen-
atom donors such as phenols, catechols, and thiols similar to O species, except that the 
reactivity has a 1:1 rather than a 2:1 stoichiometry. Redox-titrations indicate reactivity with 
ferrocene, but not with acetylferrocene, in line with a mild one-electron oxidant [17,23,93]. 
Similar to the O species, T clusters exhibit thermal decomposition through ligand N-
dealkylation, albeit at much higher temperatures suggesting a more stable complex [44]. The 
TTMCD cluster decays at −40 °C to produce formaldehyde and dealkylated ligand with a 
measured H(D) KIE of 8 supporting C-H activation as the rate limiting step. Oxygen-atom 
transfer to PPh3 is also possible, albeit performed at a higher temperature than with O 
species and presumably associated with a Cu(I) formation. Recently, trinuclear Cu clusters 
formed with a trinucleating ligand were reported by the Chan group to effect catalytic 
hydroxylation of hydrocarbon substrates including methane, using O2 and a sacrificial 
reductant. More productive hydroxylation reactivity is found using H2O2 as the oxidant in 
both homogeneous and heterogenized solutions [95,96]. The active oxidant is proposed as a 
localized valence Cu(III)Cu(II)Cu(II) mono-oxide cluster, as opposed to the μ2-oxide of the 
T clusters.
Recently, histamine ligated Cu(I) complexes were reported to react with O2 to yield 
trinuclear T clusters as the thermodynamic product, the first example of the direct formation 
of a Cu(III)-containing cluster from Cu(I) and O2 using a biologically relevant histamine 
chelate [23]. By modification of reaction conditions, non-equilibrating mixtures of O and T 
clusters could be formed from the same Cu(I)-histamine precursor. Formation kinetics 
suggest that the low energy pathway to the trinuclear T species does not involve the reaction 
of a Cu(I) species with a O species initially proposed [42], but is better understood to occur 
through the intermediacy of an unobserved 2:1 species, presumed to be a SP species (Fig. 8).
The ability to form both T and O species with the same bidentate ligand also allows for a 
direct comparison of reactivity between the two cluster types. The reaction of each species 
with ascorbic acid as a hydrogen-atom donor shows a stark difference: the T clusters 
perform the hydrogen-atom abstraction 106 times slower than the corresponding O species at 
parity of ligand. As DFT calculations suggest that the T and O clusters should have 
comparable hydrogen-atom affinities, the observed anemic reactivity of the T cluster is 
attributed to its limited accessibility, given that influence of steric demands from ligand 
substituents on reactivity is known in other Cu-O2 species [22].
Synthetic and Biological Worlds
Synthetic systems have certain advantages over biological systems in that working with 
simpler ligation reduces characterization complexity, along with the potential of working at 
lower temperatures in aprotic solvents to trap intermediates in chemical transformations. 
Low temperatures not only attenuate entropic costs of assembly, but also raise effective 
barriers to deleterious decay pathways [84]. In effect, one can consider low temperatures and 
aprotic polar solvents as surrogates for the protein matrix [37,84], especially considering the 
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dielectric inside of a protein matrix is far closer to that of an organic solvent than water 
[97,98]. As such, a synergy exists between synthetic Cu-O2 chemistry and chemistry of 
biological systems; that gleaned from one is generally applicable to the other, assuming a 
limited number of thermodynamically stable Cu-O2 structural types exist. While no enzymes 
have been observed to contain Cu(III), several enzymes have been postulated at some point 
to use a Cu(III) species for oxidative function [18,99–101].
Oxygenases vs Oxidases
Copper enzymes that directly activate O2 can generally be separated into two groups based 
on reactivity: monooxygenases and oxidases. Monooxygenases (i.e., dopamine-β-
monooxygenase (DBM), peptidylglycine-α-hydroxylating monooxygenase (PHM), lytic 
polysaccharide monooxygenases (LPM), Ty, and particulate methane monooxygenase 
(pMMO)) are a class of enzyme that hydroxylate organic molecules [4]. In this reaction, 
dioxygen is reduced to one equivalent of H2O, and the other oxygen atom is inserted into the 
C-H bond of an organic substrate. Oxidases (i.e., galactose oxidase (GO), glyoxal oxidase 
(GLOX), amine oxidase (AO), lysyl oxidase (LO), cytochrome c oxidase, and multicopper 
oxidases (MCO)) perform oxidations that are coupled to the reduction of O2 without 
incorporation of an oxygen-atom into the product. Depending on the enzyme, O2 can be 
reduced to either H2O2 or H2O. These groups can be further divided by nuclearity to allow 
for easier categorization.
Mononuclear
Mononuclear copper sites that directly activate O2 in biology are capable of hydroxylation 
reactivity (i.e., DBM, PHM, LPM) and oxidase reactivity (i.e., GO, GLOX, AO, LO) [4]. 
The reaction of O2 with reduced Cu(I) forms is postulated generally to form an initial ES 
species [20,24]. For the monooxygenase enzymes, the presumed neutral Cu(I) coordination 
yields a monocationic species that reacts with O2 to generate a non-planar Cu(II) ES species, 
crystallographically confirmed for PHM [102,103]. This geometry and hydroxylating 
reactivity is not consistent with the synthetic Cu(III) species, MP.
The oxidases, on the other hand, are proposed to react with O2 through a trigonally ligated 
Cu(I) monocationic form with two imidazoles and a ligated phenol to form a 4-coordinate 
end-on superoxide Cu(II) species. The superoxide is proposed to abstract the phenolic 
hydrogen-atom to form a hydroperoxide ligated to either one of the two valence isomers: a 
Cu(II)-phenoxyl radical or a Cu(III)-phenolate species. Assuming the former as a strongly 
antiferromagnetically coupled species, both valence isomers would be EPR silent, as 
observed experimentally [102,104]. Though initially postulated in 1973 as a Cu(III) species 
[105], subsequent spectroscopic analyses are more consistent with a Cu(II)-phenoxyl 
formulation [106].
Binuclear
Binuclear Cu-O2 sites are also known to act as both monooxygenases (i.e., Ty, Hc, pMMO) 
and oxidases (i.e., Ty, CO). Unlike the mononuclear enzymes above, Hc, Ty, and CO are 
known to share a similar oxygenated form, a SP species, despite exhibiting different 
reactivity. Protein x-ray structures of the oxygenated forms indicate each Cu center is ligated 
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in what is best described as a square pyramidal coordination with three imidazole ligands of 
histidine residues and two oxygen atoms of the peroxide moiety in a side-on fashion [88,92]. 
Each imidazole ligates through an Nτ atom with the connecting methylene substituent 
positioned remotely, creating an accessible Cu2O2 core. However, as an O2 transport protein, 
Hc does not react with exogenous substrates under native conditions, while CO is capable of 
catecholase activity (i.e., catechols to quinones), and Ty is capable of both hydroxylase (i.e., 
phenols to catechols) and catecholase reactivity [89]. The difference in reactivity between all 
these proteins is attributed largely to variation in substrate access to the Cu2O2 core, 
evidenced by Hc showing slow monooxygenase reactivity under mildly denaturing 
conditions [107,108]. Extensive reactivity and spectroscopic studies on SP-containing 
enzymes and model systems suggest that if Cu(III) is operative in any of these binuclear 
copper enzymes, it would be involved in the monooxygenase reactivity, primarily exhibited 
by Ty.
Ty are found in all aerobic life forms and are responsible for pigment biosynthesis through 
regioselective tyrosine hydroxylation to a catechol. Subsequent catechol oxidation to a 
quinone yields the pigment polymer precursor. While the products of Ty reactivity are well 
defined, the intimate details of the hydroxylation are far from complete [109–111]. The Itoh 
group have shown that the Ty hydroxylation activity can be decoupled from the catecholase 
reactivity under borate buffer conditions, where the catechol is trapped as a borate ester, 
consistent with catechol release from the binuclear site [61]. Under these conditions, the 
rate-limiting step of the hydroxylation reaction is slowed by electron deficient substrates 
(Hammett ρ = −2.4), in line with an electrophilic oxidation mechanism. The KIE of 1.1 for 
mushroom Ty with deuterium substitution on the oxidized carbon of the phenol suggests 
that the C-H(D) bond cleavage is not rate limiting [61,112].
The generally accepted hydroxylation mechanism of Ty from these and other investigations 
are deprotonation of the exogenous phenol by an active-site base, inner-sphere copper 
coordination by the phenolate, electrophilic peroxide attack on the aromatic π-system, 
followed by proton rearrangement to yield a μ-hydroxo-μ-catecholato intermediate [113]. 
Protonation of the catecholate releases catechol, generating a dicopper(II)-μ-hydroxo 
complex that can further react with the released catechol to produce quinone [89]. While no 
Cu(III) intermediate has been detected spectroscopically in biology, substantial synthetic 
experimental evidence support Cu(III)-containing O species as chemically competent to 
perform phenolate hydroxylation with reaction hallmarks similar to those of Ty. An 
alternative mechanism to that generally accepted for Ty is that peroxide bond cleavage 
occurs prior to formation of the C-O bond, which would make the O species the active 
oxidant [18,39,40] (Fig. 9).
The remaining binuclear enzyme capable of monooxygenase reactivity is pMMO, which 
has a unique proposed active site. Its structure was unknown until structural and reactivity 
studies supported a binuclear Cu active site as the site oxidation. pMMO mediates the 
remarkable transformation of methane to methanol in methanotrophic bacteria under 
ambient conditions. X-ray crystallographic and XAS investigations by the Rosenzweig 
group identify an asymmetric binuclear copper site, in which one copper is coordinated by 
two imidazole groups of histidine residues and the other is chelated by an imidazole and 
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primary amine of an N-terminal histidine, termed a histidine brace [114]. The resting state of 
the enzyme is a mixed-valence Cu(I)-Cu(II) state from XAS and EPR. However, the active 
oxidant formed with O2 is unknown currently [115,116].
In 2005, the first crystal structure of bacterial pMMO at 2.8 Å resolution revealed three 
metal sites: a Zn site, a mononuclear Cu site, and an asymmetric binuclear Cu site as 
described above [114]. Cu K-edge EXAFS modeling show a short Cu-Cu vector (ca. 2.6 Å), 
consistent with the crystal structure and supporting the postulate of a binuclear site. The 
geometry at each Cu atom in this binuclear site is nearly planar. The bidentate, planar, 
nitrogenous ligation and short Cu-Cu distance better matches the geometry and coordination 
preference of a Cu(III) O species than that of a Cu(II) SP species.
Trinuclear
The trinuclear Cu-O2 enzymes (i.e., laccase, ascorbate oxidase, Fet3p), generally referred to 
as MCO, function as oxidases removing weakly reducing electrons from substrates and 
reducing O2 by four electrons to water. The fungal laccases are remarkable for their small 
overpotential (ca. 100 mV) in the reduction of O2 [117,118]. The structure of the trinuclear 
sites are conserved largely across all MCO with the reduction site of O2 possessing three Cu 
centers within 4.5 Å [119,120], and a blue copper ET site 12 Å distant. The copper sites of 
the fully reduced trinuclear cluster are ligated differentially: two have three imidazole 
ligands while the other has two imidazoles and a water or hydroxide; seven of the eight 
imidazole ligands are Nτ ligated. The crystallographic data from the Sakurai group on a 
small MCO mutant show that oxygenation of a reduced crystal yields a tri-Cu μ3-oxide-μ2-
hydroxide species as the first and only intermediate, which upon further x-ray exposure 
degrades to the fully reduced enzyme [121]. The connectivity and metrical parameters are 
consistent with a paramagnetic Cu(II)Cu(II)Cu(II) μ3-oxide-μ2-hydroxide intermediate, or 
native intermediate, determined from extensive spectroscopic investigations by the Solomon 
group [122]. Spectroscopic investigations of several different MCO lacking their blue 
copper sites, including several from the Sakurai group, detect two intermediates, the first as 
a diamagnetic species [123–125] and the second as the native intermediate. The first 
intermediate is postulated by the Solomon group to be a Cu(I)Cu(II)Cu(II) peroxide species, 
yet no direct spectroscopic evidence of a Cu(I) center exists [121] and no 18O sensitive rR 
vibrational features in the 600–1200 cm−1 range are observed by excitation into its visible 
absorptions [121,123,126]. An alternative postulate that may merge the spectroscopic and x-
ray data is the inclusion of Cu(III) into the discussion.
Conclusions
Our knowledge of Cu-O2 chemistry over the past decades has increased rapidly since the 
discovery of Cu activating O2 in hemocyanin in 1878 [127,128]. The continued development 
of technology for the formation and characterization of Cu-O2 species (e.g., cooling baths, 
stopped-flow systems, X-ray techniques) has allowed for the understanding of general 
reactivity and characteristics of each distinct species. With these advancements comes 
clearer insight into the processes that control Cu-O2 complex formation and subsequent 
oxidative reactivity. For example, imidazole-ligated Cu(I) species should be considered as 
one or two electron reductants in reacting with O2 if a binuclear or trinuclear cluster is 
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formed and the redox potential of the resulting species should lie within the biological 
window.
The characterization of Cu(III) species that form from Cu(I) and O2 provide important 
chemical precedence to define the conditions and ligation environments for stabilization of 
this uncommon oxidation state. Defining spectroscopic and reactivity hallmarks whereby the 
presence of Cu(III) might be observed or inferred in a biological system is an exciting 
prospect. With the synthetic ligation environments moving ever closer to that observed in 
biology and knowing the tendency of these system to stabilize Cu(III), ignoring its role in 
biology becomes increasingly difficult.
Multinuclear systems have advantages over mononuclear systems for stabilizing Cu(III) as 
multiple Cu sites enable the four electron reduction of O2 to two strongly anionic oxide 
ligands. Notably, multiple Cu-O2 complexes perform Ty-like hydroxylation chemistry 
through an observable O intermediate [18,25,39,40]. The well-defined, facile SP ↔ O 
equilibrium, observed Cu(III)-containing intermediates, and nearly identical kinetic and 
thermodynamic reaction parameters (e.g., KIEs, Hammett ρ-values) support the notion of 
Cu(III) as an active player in phenol hydroxylation reactivity akin to Ty, a concept first 
proposed in 1990 [129]. For these reasons we suggest that the greatest probability of 
detection of Cu(III) in a biological system exists in a multinuclear Cu system that activates 
O2.
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Fig. 1. 
Formation of the eight structurally characterized Cu-O2 species generated in the reaction of 
Cu(I) and O2 with mono-, bi-, tri-, and tetradentate ligation (modified from Mirica et al.) 
[18].
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Fig. 2. 
Top left: Ligands that stabilize Cu(I) for reaction with O2 to produce Cu(III)-containing O 
species exclusively. Top right: Ligands that oxygenate to T species exclusively. Bottom left: 
Sufficiently compact ligands allow formation of both O and T species, dependent on their 
substituents and reaction conditions. Bottom right: β-diketiminate ligands that produce all 
three Cu(III)-containing species (MP, O, and T).
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Fig. 3. 
Optical spectra of a bis-Cu(II) TP (left), bis-Cu(II) SP (middle), and a bis-Cu(III) O species 
(right).
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Fig. 4. 
Comparison of Cu(III/II) potentials for Cu(III) complexes with varied donor strength and 
overall complex charge. Adapted from Hanss et al. [55].
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Fig. 5. 
The lowest energy DFT calculated pathway for C-H bond activation from cyclohexanediene 
(CHD) along the O-O vector of OPD [21].
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Fig. 6. 
Cu-O2 complexes known to perform ortho-hydroxylation of exogenous phenolates through a 
O active oxidant. Reactions with complexes a, b, and c proceed through an observed, 
phenolate-bonded Cu(III) intermediate [18,39,40]. Complexes d, e, and f are proposed to 
react in a similar fashion, although no Cu(III) intermediates are detected spectroscopically 
[25,28,38,91].
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Fig. 7. 
Left: The oxygenated form of Ty and Hc displaying exclusive Nτ imidazole ligation to the 
Cu centers [88,92]. Right: The SP species formed from oxygenation of Cu(I) and 1,2-
dimethylimidazole showing exclusively Nπ imidazole ligation [37].
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Fig. 8. 
Proposed formation mechanism of the trinuclear cluster given observed formation kinetics 
[23].
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Fig. 9. 
Two potential phenol hydroxylation mechanisms by Ty. Oxygenation to a SP species, 
followed by phenolate ligation with imidazole dissociation creates Int1. The generally 
accepted biological mechanism involves a rate limiting concerted C-O bond formation with 
C-H bond cleavage to Int2. Alternatively, phenolate rearrangement could trigger O-O bond 
cleavage, followed by a rate limiting C-H insertion to Int2.
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